Criteria and diagnostic accuracy of tests for predicting segmental recovery of dysfunction after revascularization
| Method (ref) . | Criteria . | Sensitivity (95% CI) . | Specificity (95% CI) . | DOR (95% CI) . | PPV (95% CI) . | NPV (95% CI) . |
|---|---|---|---|---|---|---|
| LDD-TTE71 | Improvement of WMS > 1 | 81 (80–82) | 80 (79–81) | 24.53 (24.32–24.74) | 77 (76–78) | 85 (84–86) |
| SPECT | ||||||
| 201-Tl71 | Preserved resting perfusion or redistribution | 86 (84–88) | 59 (56–62) | 8.79 (8.60–8.98) | 69 (67–71) | 80 (77–83) |
| 99Tc tracers71 | Preserved resting perfusion | 81 (78–84) | 66 (63–69) | 5.40 (8.60–8.98) | 71 (68–74) | 77 (74–80) |
| FDG PET71 | Preserved FDG in sector with reduced perfusion | 93 (91–95) | 58 (54–62) | 18.16 (17.85–18.46) | 71 (68–74) | 86 (83–89) |
| CMR | ||||||
| LGE92 | <25% transmurality | 95 (93–97) | 51 (40–62) | 21.12 (10.98–40.55) | 69 (56–80) | 90 (85–93) |
| LDD92 | Improvement of WMS > 1 | 81 (73–86) | 91 (84–95) | 41.57 (18.25–94.68) | 93 (87–97) | 75 (65–83) |
| Method (ref) . | Criteria . | Sensitivity (95% CI) . | Specificity (95% CI) . | DOR (95% CI) . | PPV (95% CI) . | NPV (95% CI) . |
|---|---|---|---|---|---|---|
| LDD-TTE71 | Improvement of WMS > 1 | 81 (80–82) | 80 (79–81) | 24.53 (24.32–24.74) | 77 (76–78) | 85 (84–86) |
| SPECT | ||||||
| 201-Tl71 | Preserved resting perfusion or redistribution | 86 (84–88) | 59 (56–62) | 8.79 (8.60–8.98) | 69 (67–71) | 80 (77–83) |
| 99Tc tracers71 | Preserved resting perfusion | 81 (78–84) | 66 (63–69) | 5.40 (8.60–8.98) | 71 (68–74) | 77 (74–80) |
| FDG PET71 | Preserved FDG in sector with reduced perfusion | 93 (91–95) | 58 (54–62) | 18.16 (17.85–18.46) | 71 (68–74) | 86 (83–89) |
| CMR | ||||||
| LGE92 | <25% transmurality | 95 (93–97) | 51 (40–62) | 21.12 (10.98–40.55) | 69 (56–80) | 90 (85–93) |
| LDD92 | Improvement of WMS > 1 | 81 (73–86) | 91 (84–95) | 41.57 (18.25–94.68) | 93 (87–97) | 75 (65–83) |
CMR, cardiovascular magnetic resonance; FDG, fluorodeoxyglucose; LDD, low-dose dobutamine; LGE, late-gadolinium enhancement; PET, positron emission tomography; SPECT, single photon emission computed tomography.
Criteria and diagnostic accuracy of tests for predicting segmental recovery of dysfunction after revascularization
| Method (ref) . | Criteria . | Sensitivity (95% CI) . | Specificity (95% CI) . | DOR (95% CI) . | PPV (95% CI) . | NPV (95% CI) . |
|---|---|---|---|---|---|---|
| LDD-TTE71 | Improvement of WMS > 1 | 81 (80–82) | 80 (79–81) | 24.53 (24.32–24.74) | 77 (76–78) | 85 (84–86) |
| SPECT | ||||||
| 201-Tl71 | Preserved resting perfusion or redistribution | 86 (84–88) | 59 (56–62) | 8.79 (8.60–8.98) | 69 (67–71) | 80 (77–83) |
| 99Tc tracers71 | Preserved resting perfusion | 81 (78–84) | 66 (63–69) | 5.40 (8.60–8.98) | 71 (68–74) | 77 (74–80) |
| FDG PET71 | Preserved FDG in sector with reduced perfusion | 93 (91–95) | 58 (54–62) | 18.16 (17.85–18.46) | 71 (68–74) | 86 (83–89) |
| CMR | ||||||
| LGE92 | <25% transmurality | 95 (93–97) | 51 (40–62) | 21.12 (10.98–40.55) | 69 (56–80) | 90 (85–93) |
| LDD92 | Improvement of WMS > 1 | 81 (73–86) | 91 (84–95) | 41.57 (18.25–94.68) | 93 (87–97) | 75 (65–83) |
| Method (ref) . | Criteria . | Sensitivity (95% CI) . | Specificity (95% CI) . | DOR (95% CI) . | PPV (95% CI) . | NPV (95% CI) . |
|---|---|---|---|---|---|---|
| LDD-TTE71 | Improvement of WMS > 1 | 81 (80–82) | 80 (79–81) | 24.53 (24.32–24.74) | 77 (76–78) | 85 (84–86) |
| SPECT | ||||||
| 201-Tl71 | Preserved resting perfusion or redistribution | 86 (84–88) | 59 (56–62) | 8.79 (8.60–8.98) | 69 (67–71) | 80 (77–83) |
| 99Tc tracers71 | Preserved resting perfusion | 81 (78–84) | 66 (63–69) | 5.40 (8.60–8.98) | 71 (68–74) | 77 (74–80) |
| FDG PET71 | Preserved FDG in sector with reduced perfusion | 93 (91–95) | 58 (54–62) | 18.16 (17.85–18.46) | 71 (68–74) | 86 (83–89) |
| CMR | ||||||
| LGE92 | <25% transmurality | 95 (93–97) | 51 (40–62) | 21.12 (10.98–40.55) | 69 (56–80) | 90 (85–93) |
| LDD92 | Improvement of WMS > 1 | 81 (73–86) | 91 (84–95) | 41.57 (18.25–94.68) | 93 (87–97) | 75 (65–83) |
CMR, cardiovascular magnetic resonance; FDG, fluorodeoxyglucose; LDD, low-dose dobutamine; LGE, late-gadolinium enhancement; PET, positron emission tomography; SPECT, single photon emission computed tomography.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
